Dermata Therapeutics's total assets for Q3 2025 were $5.07M, a decrease of -23.63% from the previous quarter. DRMA total liabilities were $1.11M for the fiscal quarter, a 8.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.